Patent
   D430285
Priority
Apr 16 1999
Filed
Apr 16 1999
Issued
Aug 29 2000
Expiry
Aug 29 2014
Assg.orig
Entity
unknown
21
20
n/a
The ornamental design for a tablet, as shown and described.

FIG. 1 is a top plan view of a tablet showing our new design;

FIG. 2 is a bottom plan view thereof;

FIG. 3 is a front elevational view thereof;

FIG. 4 is a rear elevational view thereof;

FIG. 5 is a side elevational view thereof, the other side being identical;

FIG. 6 is a top perspective view thereof, on an enlarged scale; and,

FIG. 7 is a bottom perspective view thereof, on an enlarged scale.

Katdare, Ashok V., Chen, Tzyy-Show H., Nyairo, Thomas G.

Patent Priority Assignee Title
10285439, Dec 10 2010 Altria Client Services LLC Smokeless tobacco packaging system and method
10327467, Apr 14 2010 Altria Client Services LLC Preformed smokeless tobacco product
10645968, Apr 14 2010 Altria Client Services LLC Preformed smokeless tobacco product
11357256, Dec 10 2010 Altria Client Services LLC Smokeless tobacco packaging system and method
9237768, Apr 14 2010 Altria Client Services LLC Preformed smokeless tobacco product
9468233, Dec 10 2010 Altria Client Services LLC Smokeless tobacco packaging system and method
D452562, Feb 06 2001 Gilead Sciences, Inc. Tablet
D636070, Feb 26 2010 AstraZeneca AB Tablet
D636865, Aug 25 2010 KVK-Tech, Inc. Pharmaceutical tablet
D666376, Dec 01 2010 Intercontinental Great Brands LLC Lozenge
D666377, Dec 01 2010 Intercontinental Great Brands LLC Lozenge
D674134, Dec 10 2010 Altria Client Services LLC Oral tobacco article
D685460, Aug 27 2009 AstraZeneca AB Tablet
D787042, Apr 28 2015 Celgene Corporation Pharmaceutical tablet
D787043, Jun 23 2015 Celgene Corporation Pharmaceutical tablet
D813372, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D835257, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D835258, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D858741, Feb 22 2017 Celgene Corporation Pharmaceutical tablet
D907760, Jan 20 2017 SOCIÉTÉ DES PRODUITS NESTLÉ S A Orally ingestible tablet
D947358, Mar 19 2019 Novo Nordisk A/S Pill
Patent Priority Assignee Title
2687367,
4693886, Apr 22 1985 ALZA Corporation Osmotic device with inert core
4851228, Jun 20 1984 MERCK & CO , INC , A CORP OF NJ Multiparticulate controlled porosity osmotic
5424074, Jun 20 1989 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical composition for potassium supplementation
5427798, Aug 14 1992 SMITHKLINE BEECHAM CORPORATION, A PENNSYLVANIA CORPORATION Controlled sustained release tablets containing bupropion
5512299, Mar 30 1992 ALZA Corporation Method of treating oral inflammatory disease
5770225, Apr 28 1989 McNeil-PPC, Inc. Process of preparing a subcoated simulated capsule-like medicament
5824338, Aug 19 1996 L. PERRIGO COMPANY Caplet and gelatin covering therefor
216307,
D258091, Aug 31 1978 Marion Laboratories, Inc. Pharmaceutical tablet
D301764, Dec 21 1987 RHONE-POULENC RORER PHARMACEUTICALS INC Pharmaceutical tablet
D302051, Dec 21 1987 RHONE-POULENC RORER PHARMACEUTICALS INC Pharmaceutical tablet
D316914, Aug 01 1989 MERRELL DOW PHARMACEUTICALS LTD Tablet
D359554, Dec 02 1991 The Procter & Gamble Company Tablet
D375157, Dec 22 1992 Merck Sharp & Dohme Corp Tablet
D379223, Sep 13 1995 Merck Sharp & Dohme Corp Pharmaceutical tablet
D380825, Oct 31 1994 Merck Sharp & Dohme Corp Pharmaceutical tablet
D400672, Mar 21 1996 Merck Sharp & Dohme Corp Pharmaceutical tablet
D403396, Nov 28 1996 Astra Aktiebolag Tablet
56478,
////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Apr 16 1999Merck & Co., Inc.(assignment on the face of the patent)
Sep 08 1999KATDARE, ASHOK V MERCK & CO , INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0106950140 pdf
Sep 10 1999CHEN, TZYY-SHOW H MERCK & CO , INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0106950269 pdf
Sep 10 1999NYAIRO, THOMAS G MERCK & CO , INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0106950269 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule